Company Filing History:
Years Active: 2020
Title: Harm Jan Snijder: Innovator in Neuropathic Pain Treatment
Introduction
Harm Jan Snijder is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating neuropathic pain and other medical conditions.
Latest Patents
Harm Jan Snijder holds a patent for "P2X4 antibodies and uses thereof." This invention provides antibodies that specifically bind to a P2X4 polypeptide and modulate P2X4 channel activity. The patent also includes recombinant P2X4 polypeptides and methods for generating such polypeptides. Additionally, it outlines compositions and methods for generating anti-P2X4 antibodies, as well as methods of using these antibodies for the treatment of neuropathic pain and other indications. He has 1 patent to his name.
Career Highlights
Harm Jan Snijder is currently associated with MedImmune Limited, a leading biotechnology company. His role involves research and development of innovative therapeutic solutions. His expertise in antibody technology has positioned him as a key player in the field.
Collaborations
Harm Jan Snijder collaborates with talented professionals in his field, including Wendy A. Williams and Clare Jones. These collaborations enhance the research and development efforts at MedImmune Limited.
Conclusion
Harm Jan Snijder is a pioneering inventor whose work in P2X4 antibodies represents a significant advancement in the treatment of neuropathic pain. His contributions to biotechnology continue to impact the medical field positively.